Results 131 to 140 of about 63,380,474 (215)

H-score and ERBB2 mRNA refine identification of HER2-low and HER2-ultralow breast cancer. [PDF]

open access: yesBreast Cancer Res
Sartori GP   +16 more
europepmc   +1 more source

Ensemble machine learning for predicting breast cancer recurrence and mortality using clinical and hemogram data. [PDF]

open access: yesNPJ Breast Cancer
Moreira PH   +11 more
europepmc   +1 more source

Survival time analysis in women with breast cancer using distributional regression models. [PDF]

open access: yesCad Saude Publica
Lima IDS   +6 more
europepmc   +1 more source

Five-year overall and specific survival of breast cancer in great Cuiaba (MT), Brazil. [PDF]

open access: yesRev Bras Epidemiol
Oliveira JCS   +3 more
europepmc   +1 more source

Cancer outcomes in patients eligible for adjuvant cyclin-dependent kinase 4 and 6 inhibitors but spared adjuvant chemotherapy by Oncotype Dx: A multicenter retrospective GBECAM 0520 study. [PDF]

open access: yesBreast
Oliveira LJC   +28 more
europepmc   +1 more source

Prognostic Impact of AGR3 Protein Expression in Breast Cancer: A Systematic Review and Meta-analysis. [PDF]

open access: yesRev Bras Ginecol Obstet, 2023
Moraes CL   +5 more
europepmc   +1 more source

Efficacy and Genomic Analysis of HER2-Mutant Metastatic Triple-Negative Breast Cancer Treated with Neratinib Alone or with Trastuzumab in the SUMMIT Basket Trial. [PDF]

open access: yesClin Cancer Res
Jhaveri K   +18 more
europepmc   +1 more source

New Cardiovascular Biomarkers in Breast Cancer Patients Undergoing Doxorubicin-Based Chemotherapy. [PDF]

open access: yesArq Bras Cardiol, 2023
Pestana RMC   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy